Angstrom Pharmaceuticals' Series B Round

Angstrom Pharmaceuticals raised a round of funding on June 20, 2003.

Angstrom Pharmaceuticals, a privately held pharmaceutical company headquartered in San Diego, California, is developing a new class of proprietary drugs that treat diseases involving cell migration, i…

Articles about Angstrom Pharmaceuticals' Series B Round: